(Q40027537)

16 September 2017

title

Tumor protection following vaccination with low doses of lentivirally transduced DCs expressing the self-antigen erbB2. (English)

1 reference

16 September 2017

Jonathan L Bramson

8

0 references

author name string

Miriam E Mossoba

1

1 reference

16 September 2017

Jagdeep S Walia

2

1 reference

16 September 2017

Vanessa I Rasaiah

3

1 reference

16 September 2017

Nicole Buxhoeveden

4

1 reference

16 September 2017

Renee Head

5

1 reference

16 September 2017

Chuyan Ying

6

1 reference

16 September 2017

Jason E Foley

7

1 reference

16 September 2017

Daniel H Fowler

9

1 reference

16 September 2017

Jeffrey A Medin

10

1 reference

16 September 2017

publication date

8 January 2008

1 reference

16 September 2017

1 reference

16 September 2017

volume

16

1 reference

16 September 2017

issue

3

1 reference

16 September 2017

page(s)

607-617

1 reference

An APC for every occasion: induction and expansion of human Ag-specific CD4 and CD8 T cells using cellular and non-cellular APC

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300390

7 January 2021

Immune and clinical outcomes in patients with stage IV melanoma vaccinated with peptide-pulsed dendritic cells derived from CD34+ progenitors and activated with type I interferon.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300390

7 January 2021

Vaccination of advanced hepatocellular carcinoma patients with tumor lysate-pulsed dendritic cells: a clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300390

7 January 2021

Vaccination of colorectal cancer patients with CEA-loaded dendritic cells: antigen-specific T cell responses in DTH skin tests

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300390

7 January 2021

Generation of carcinoembryonic antigen (CEA)-specific T-cell responses in HLA-A*0201 and HLA-A*2402 late-stage colorectal cancer patients after vaccination with dendritic cells loaded with CEA peptides

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300390

7 January 2021

Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300390

7 January 2021

Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300390

7 January 2021

Current methods for loading dendritic cells with tumor antigen for the induction of antitumor immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300390

7 January 2021

Immunization with lentiviral vector-transduced dendritic cells induces strong and long-lasting T cell responses and therapeutic immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300390

7 January 2021

Skin-derived dendritic cells induce potent CD8(+) T cell immunity in recombinant lentivector-mediated genetic immunization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300390

7 January 2021

Use of a lentiviral flap vector for induction of CTL immunity against melanoma. Perspectives for immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300390

7 January 2021

Lentiviral vector-mediated tyrosinase-related protein 2 gene transfer to dendritic cells for the therapy of melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300390

7 January 2021

Cancer immunotherapy using virally transduced dendritic cells: animal studies and human clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300390

7 January 2021

Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300390

7 January 2021

HER2/neu expression in malignant lung tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300390

7 January 2021

A truncated intracellular HER2/neu receptor produced by alternative RNA processing affects growth of human carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300390

7 January 2021

Bioluminescent imaging of a marking transgene and correction of Fabry mice by neonatal injection of recombinant lentiviral vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300390

7 January 2021

Enhanced therapeutic effect of HSV-tk+GCV gene therapy and ionizing radiation for prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300390

7 January 2021

Efficient transfer of PSA and PSMA cDNAs into DCs generates antibody and T cell antitumor responses in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300390

7 January 2021

Side-by-side comparison of lentivirally transduced and mRNA-electroporated dendritic cells: implications for cancer immunotherapy protocols.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300390

7 January 2021

In vivo gene transfer into adult stem cells in unconditioned mice by in situ delivery of a lentiviral vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300390

7 January 2021

Importance of murine study design for testing toxicity of retroviral vectors in support of phase I trials.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300390

7 January 2021

Intrapulmonary and intramyocardial gene transfer in rhesus monkeys (Macaca mulatta): safety and efficiency of HIV-1-derived lentiviral vectors for fetal gene delivery

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300390

7 January 2021

Gene transfer in humans using a conditionally replicating lentiviral vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300390

7 January 2021

HER-2/neu-gene engineered dendritic cell vaccine stimulates stronger HER-2/neu-specific immune responses compared to DNA vaccination

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300390

7 January 2021

Enhanced HER-2/neu-specific antitumor immunity by cotransduction of mouse dendritic cells with two genes encoding HER-2/neu and alpha tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300390

7 January 2021

Vaccination by genetically modified dendritic cells expressing a truncated neu oncogene prevents development of breast cancer in transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300390

7 January 2021

The generation of both T killer and Th cell clones specific for the tumor-associated antigen HER2 using retrovirally transduced dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300390

7 January 2021

Expression of the myeloid-associated marker CD33 is not an exclusive factor for leukemic plasmacytoid dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300390

7 January 2021

Acute differentiated dendritic cell leukemia: a variant form of pediatric acute myeloid leukemia with MLL translocation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300390

7 January 2021

CD4(+) CD56(+) lineage-negative malignancies are rare tumors of plasmacytoid dendritic cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300390

7 January 2021

Acute leukemia of dendritic cell lineage in childhood: incidence, biological characteristics and outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300390

7 January 2021

Plasmacytoid dendritic cell leukaemia/lymphoma: towards a well defined entity?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300390

7 January 2021

Engineered human tmpk/AZT as a novel enzyme/prodrug axis for suicide gene therapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300390

7 January 2021

Ex vivo generation of genetically modified dendritic cells for immunotherapy: implications of lymphocyte contamination

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300390

7 January 2021

An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300390

7 January 2021

Specific pharmacological dimerization of KDR in lentivirally transduced human hematopoietic cells activates anti-apoptotic and proliferative mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300390

7 January 2021

Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300390

7 January 2021

Circulating alpha-galactosidase A derived from transduced bone marrow cells: relevance for corrective gene transfer for Fabry disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300390

7 January 2021

Quantitative measurement of anti-ErbB-2 antibody by flow cytometry and ELISA.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300390

7 January 2021

Identifiers

DOI

10.1038/SJ.MT.6300390

1 reference

16 September 2017

1 reference